The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X-ray hysterosalpingography for the investigation of infertility patients
A. Strandell et al., The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X-ray hysterosalpingography for the investigation of infertility patients, ULTRASOUN O, 14(3), 1999, pp. 200-204
Objectives The aim of the present study was to examine the role of hysteros
alpingocontrast sonography (HyCoSy) as a screening test for endometrial and
tubal Pathology at the start of the infertility investigation protocol.
Methods HyCoSy was compared with X-ray hysterosalpingography (HSG) for the
assessment of the endometrial cavity and Fallopian tube patency. A total of
103 women with a history of at least 1 year's infertility were included. E
ach woman underwent both HyCoSy and HSG on the same day. Laparoscopy was pe
rformed in 43 cases. For HyCoSy examinations, saline was used for evaluatio
n of the endometrial cavity and Echovist(R) contrast medium to assess Fallo
pian tube patency.
Results The concordance between HyCoSy and HSG for the presence of endometr
ial cavity pathology was 90%, but for tubal patency the concordance was low
er (72%). HyCoSy classed more examinations of tubal patency as uncertain. H
SG more frequently classified tubes as occluded. In the subset of patients
in whom all three techniques were used, HSG and HyCoSy demonstrated a high
concordance with laparoscopy (83% and 80%, respectively). The prevalence of
occluded tubes according to laparoscopy as the reference standard was 13%.
The two methods had a high negative predictive value for tubal disease (HS
G, 94%; HyCoSy, 88%), and the positive predictive values were 47% and 75%,
respectively. The detection rate for occluded tubes was 73% and 27%, and sp
ecificity 87% and 90%, respectively.
Conclusions Our data demonstrate that HyCoSy obtains similar information ab
out the status of the endometrial cavity and Fallopian tube patency to that
of HSG. It is possible that in some cases HyCoSy may replace HSG in order
to select women with patent tubes who may be suitable for further infertili
ty treatment without more invasive investigation.